Please Wait a Moment
X

Articles

29Apr

Convalescent Plasma Testing for COVID-19

29 Apr, 2020 | Return|

CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.

The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications

We will be sending updates as we get more details to share with you!

Related

Pooled Zika Testing and New CTS Website Functionality- November 29th Update

As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...

Read More >

Update on the Ortho Conversion

At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...

Read More >

Reminder- Health and Human Services (HHS) email notifications for WNV reactives

Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...

Read More >

Preparing for Hurricane Florence

As the US coast prepares for Hurricane Florence to make landfall, we have received importan...

Read More >

FDA Updates Emergency Use Authorization for COVID-19 Convalescent Plasma

On December 28, 2021, the FDA updated the emergency use authorization  (EUA) for COVID-19 conva...

Read More >

CTS to Implement the Grifols Procleix Ultrio Elite Assay Beginning June 1, 2020

Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...

Read More >